company background image
EKTA

Elekta OM:EKTA B Stock Report

Last Price

kr70.66

Market Cap

kr27.0b

7D

0.5%

1Y

-43.1%

Updated

30 Jun, 2022

Data

Company Financials +
EKTA B fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends3/6

EKTA B Stock Overview

Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide.

Elekta Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Elekta
Historical stock prices
Current Share Pricekr70.66
52 Week Highkr132.35
52 Week Lowkr62.60
Beta0.89
1 Month Change-7.03%
3 Month Change-8.45%
1 Year Change-43.11%
3 Year Change-47.54%
5 Year Change-10.61%
Change since IPO417.02%

Recent News & Updates

Jun 23
When Should You Buy Elekta AB (publ) (STO:EKTA B)?

When Should You Buy Elekta AB (publ) (STO:EKTA B)?

While Elekta AB (publ) ( STO:EKTA B ) might not be the most widely known stock at the moment, it received a lot of...

Apr 28
Elekta (STO:EKTA B) Seems To Use Debt Quite Sensibly

Elekta (STO:EKTA B) Seems To Use Debt Quite Sensibly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

EKTA BSE Medical EquipmentSE Market
7D0.5%2.2%-0.06%
1Y-43.1%-35.8%-22.4%

Return vs Industry: EKTA B underperformed the Swedish Medical Equipment industry which returned -35.8% over the past year.

Return vs Market: EKTA B underperformed the Swedish Market which returned -22.4% over the past year.

Price Volatility

Is EKTA B's price volatile compared to industry and market?
EKTA B volatility
EKTA B Average Weekly Movement5.7%
Medical Equipment Industry Average Movement8.2%
Market Average Movement7.4%
10% most volatile stocks in SE Market12.3%
10% least volatile stocks in SE Market4.7%

Stable Share Price: EKTA B is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: EKTA B's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19724,631Gustaf Salfordhttps://www.elekta.com

Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems.

Elekta Fundamentals Summary

How do Elekta's earnings and revenue compare to its market cap?
EKTA B fundamental statistics
Market Capkr26.96b
Earnings (TTM)kr1.15b
Revenue (TTM)kr14.55b

23.4x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EKTA B income statement (TTM)
Revenuekr14.55b
Cost of Revenuekr9.11b
Gross Profitkr5.44b
Other Expenseskr4.28b
Earningskr1.15b

Last Reported Earnings

Apr 30, 2022

Next Earnings Date

Jul 08, 2022

Earnings per share (EPS)3.02
Gross Margin37.37%
Net Profit Margin7.93%
Debt/Equity Ratio51.7%

How did EKTA B perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

79%

Payout Ratio

Does EKTA B pay a reliable dividends?

See EKTA B dividend history and benchmarks
When do you need to buy EKTA B by to receive an upcoming dividend?
Elekta dividend dates
Ex Dividend DateAug 26 2022
Dividend Pay DateSep 01 2022
Days until Ex dividend56 days
Days until Dividend pay date62 days

Does EKTA B pay a reliable dividends?

See EKTA B dividend history and benchmarks
We’ve recently updated our valuation analysis.

Valuation

Is EKTA B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EKTA B?

Other financial metrics that can be useful for relative valuation.

EKTA B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2x
Enterprise Value/EBITDA14.5x
PEG Ratio1.4x

Price to Earnings Ratio vs Peers

How does EKTA B's PE Ratio compare to its peers?

EKTA B PE Ratio vs Peers
The above table shows the PE ratio for EKTA B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average32.9x
ARJO B Arjo
24x19.8%kr17.6b
GETI B Getinge
22.5x13.7%kr63.9b
CEVI CellaVision
59.6x19.6%kr8.3b
ELOS B Elos Medtech
25.7xn/akr2.0b
EKTA B Elekta
23.4x16.7%kr27.0b

Price-To-Earnings vs Peers: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the peer average (32.9x).


Price to Earnings Ratio vs Industry

How does EKTA B's PE Ratio compare vs other companies in the European Medical Equipment Industry?

Price-To-Earnings vs Industry: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the Swedish Medical Equipment industry average (36.5x)


Price to Earnings Ratio vs Fair Ratio

What is EKTA B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EKTA B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.4x
Fair PE Ratio38.5x

Price-To-Earnings vs Fair Ratio: EKTA B is good value based on its Price-To-Earnings Ratio (23.4x) compared to the estimated Fair Price-To-Earnings Ratio (38.5x).


Share Price vs Fair Value

What is the Fair Price of EKTA B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EKTA B (SEK70.66) is trading below our estimate of fair value (SEK168.08)

Significantly Below Fair Value: EKTA B is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: EKTA B is poor value based on its PEG Ratio (1.4x)


Discover undervalued companies

Future Growth

How is Elekta forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EKTA B's forecast earnings growth (16.7% per year) is above the savings rate (0.4%).

Earnings vs Market: EKTA B's earnings (16.7% per year) are forecast to grow faster than the Swedish market (9.6% per year).

High Growth Earnings: EKTA B's earnings are forecast to grow, but not significantly.

Revenue vs Market: EKTA B's revenue (7.6% per year) is forecast to grow faster than the Swedish market (5.5% per year).

High Growth Revenue: EKTA B's revenue (7.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: EKTA B's Return on Equity is forecast to be low in 3 years time (17%).


Discover growth companies

Past Performance

How has Elekta performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


10.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EKTA B has high quality earnings.

Growing Profit Margin: EKTA B's current net profit margins (7.9%) are lower than last year (9.1%).


Past Earnings Growth Analysis

Earnings Trend: EKTA B's earnings have grown by 10.4% per year over the past 5 years.

Accelerating Growth: EKTA B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: EKTA B had negative earnings growth (-8%) over the past year, making it difficult to compare to the Medical Equipment industry average (6.3%).


Return on Equity

High ROE: EKTA B's Return on Equity (13%) is considered low.


Discover strong past performing companies

Financial Health

How is Elekta's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: EKTA B's short term assets (SEK12.9B) exceed its short term liabilities (SEK11.6B).

Long Term Liabilities: EKTA B's short term assets (SEK12.9B) exceed its long term liabilities (SEK5.8B).


Debt to Equity History and Analysis

Debt Level: EKTA B's net debt to equity ratio (17.2%) is considered satisfactory.

Reducing Debt: EKTA B's debt to equity ratio has reduced from 76.8% to 51.7% over the past 5 years.

Debt Coverage: EKTA B's debt is well covered by operating cash flow (40.3%).

Interest Coverage: EKTA B's interest payments on its debt are well covered by EBIT (10.5x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Elekta current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


3.40%

Current Dividend Yield

Upcoming Dividend Payment

TodayJun 30 2022Ex Dividend DateAug 26 2022Dividend Pay DateSep 01 20226 days from Ex DividendBuy in the next 56 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: EKTA B's dividend (3.4%) is higher than the bottom 25% of dividend payers in the Swedish market (1.65%).

High Dividend: EKTA B's dividend (3.4%) is low compared to the top 25% of dividend payers in the Swedish market (5.33%).


Stability and Growth of Payments

Stable Dividend: EKTA B's dividend payments have been volatile in the past 10 years.

Growing Dividend: EKTA B's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: At its current payout ratio (79.5%), EKTA B's payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (203.8%), EKTA B's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

5.4yrs

Average management tenure


CEO

Gustaf Salford (44 yo)

2yrs

Tenure

kr13,097,530

Compensation

Mr. Gustaf Salford serves as President and Chief Executive Officer at Elekta AB (publ) since November 26, 2020 and served as its Acting President and Chief Executive Officer since June 2, 2020 until Novemb...


CEO Compensation Analysis

Compensation vs Market: Gustaf's total compensation ($USD1.28M) is about average for companies of similar size in the Swedish market ($USD1.77M).

Compensation vs Earnings: Insufficient data to compare Gustaf's compensation with company performance.


Leadership Team

Experienced Management: EKTA B's management team is seasoned and experienced (5.4 years average tenure).


Board Members

Experienced Board: EKTA B's board of directors are seasoned and experienced ( 11.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: EKTA B insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Elekta AB (publ)'s employee growth, exchange listings and data sources


Key Information

  • Name: Elekta AB (publ)
  • Ticker: EKTA B
  • Exchange: OM
  • Founded: 1972
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: kr26.960b
  • Shares outstanding: 382.08m
  • Website: https://www.elekta.com

Number of Employees


Location

  • Elekta AB (publ)
  • Kungstensgatan 18
  • Box 7593
  • Stockholm
  • Stockholm County
  • 103 93
  • Sweden

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/30 00:00
End of Day Share Price2022/06/30 00:00
Earnings2022/04/30
Annual Earnings2022/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.